Rapid group B streptococci screening using a real-time polymerase chain reaction assay

Rodney K. Edwards, Susan M. Novak-Weekley, Patrick P. Koty, Thomas Davis, Leroy J. Leeds, Jeanne A. Jordan

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

OBJECTIVE:: To estimate the clinical performance characteristics of a real-time polymerase chain reaction (PCR) assay using vaginal/rectal swabs from antepartum (35-37 weeks of gestation) and intrapartum women. METHODS:: The assay evaluated is a qualitative, automated, real-time PCR test for the detection of group B streptococci, with results available in approximately 75 minutes. Enrollment in this multicenter clinical study occurred between October 2005 and January 2006. Vaginal/rectal swabs were analyzed by nursing personnel (intrapartum tests) or by laboratory technologists (all others). Polymerase chain reaction assay results were compared with culture using standard methods, including selective broth medium, and to a predicate nucleic acid amplification test. RESULTS:: Of 1,028 enrolled women, 234 were deemed ineligible, and 10 had unresolved test results. Of the 784 remaining women, valid PCR assay results were obtained on the first test attempt for 93.0%. Performance characteristics relative to culture were sensitivity 91.1%, specificity 96.0%, positive predictive value 87.8%, negative predictive value 97.1%, and accuracy 94.8%. These results exceeded those obtained using the predicate nucleic acid amplification test. CONCLUSION:: Performance characteristics of the PCR assay exceed the threshold recommended by the Centers for Disease Control and Prevention when compared with culture. The test is sufficiently robust to be performed for intrapartum patients in a point-of-care setting by medical professionals.

Original languageEnglish (US)
Pages (from-to)1335-1341
Number of pages7
JournalObstetrics and Gynecology
Volume111
Issue number6
DOIs
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Streptococcus agalactiae
Nucleic Acid Amplification Techniques
Real-Time Polymerase Chain Reaction
Polymerase Chain Reaction
Point-of-Care Systems
Centers for Disease Control and Prevention (U.S.)
Multicenter Studies
Nurses
Sensitivity and Specificity
Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Edwards, R. K., Novak-Weekley, S. M., Koty, P. P., Davis, T., Leeds, L. J., & Jordan, J. A. (2008). Rapid group B streptococci screening using a real-time polymerase chain reaction assay. Obstetrics and Gynecology, 111(6), 1335-1341. https://doi.org/10.1097/AOG.0b013e31817710ee

Rapid group B streptococci screening using a real-time polymerase chain reaction assay. / Edwards, Rodney K.; Novak-Weekley, Susan M.; Koty, Patrick P.; Davis, Thomas; Leeds, Leroy J.; Jordan, Jeanne A.

In: Obstetrics and Gynecology, Vol. 111, No. 6, 06.2008, p. 1335-1341.

Research output: Contribution to journalArticle

Edwards, Rodney K. ; Novak-Weekley, Susan M. ; Koty, Patrick P. ; Davis, Thomas ; Leeds, Leroy J. ; Jordan, Jeanne A. / Rapid group B streptococci screening using a real-time polymerase chain reaction assay. In: Obstetrics and Gynecology. 2008 ; Vol. 111, No. 6. pp. 1335-1341.
@article{97019925ab1f462fae188a39943bd84f,
title = "Rapid group B streptococci screening using a real-time polymerase chain reaction assay",
abstract = "OBJECTIVE:: To estimate the clinical performance characteristics of a real-time polymerase chain reaction (PCR) assay using vaginal/rectal swabs from antepartum (35-37 weeks of gestation) and intrapartum women. METHODS:: The assay evaluated is a qualitative, automated, real-time PCR test for the detection of group B streptococci, with results available in approximately 75 minutes. Enrollment in this multicenter clinical study occurred between October 2005 and January 2006. Vaginal/rectal swabs were analyzed by nursing personnel (intrapartum tests) or by laboratory technologists (all others). Polymerase chain reaction assay results were compared with culture using standard methods, including selective broth medium, and to a predicate nucleic acid amplification test. RESULTS:: Of 1,028 enrolled women, 234 were deemed ineligible, and 10 had unresolved test results. Of the 784 remaining women, valid PCR assay results were obtained on the first test attempt for 93.0{\%}. Performance characteristics relative to culture were sensitivity 91.1{\%}, specificity 96.0{\%}, positive predictive value 87.8{\%}, negative predictive value 97.1{\%}, and accuracy 94.8{\%}. These results exceeded those obtained using the predicate nucleic acid amplification test. CONCLUSION:: Performance characteristics of the PCR assay exceed the threshold recommended by the Centers for Disease Control and Prevention when compared with culture. The test is sufficiently robust to be performed for intrapartum patients in a point-of-care setting by medical professionals.",
author = "Edwards, {Rodney K.} and Novak-Weekley, {Susan M.} and Koty, {Patrick P.} and Thomas Davis and Leeds, {Leroy J.} and Jordan, {Jeanne A.}",
year = "2008",
month = "6",
doi = "10.1097/AOG.0b013e31817710ee",
language = "English (US)",
volume = "111",
pages = "1335--1341",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Rapid group B streptococci screening using a real-time polymerase chain reaction assay

AU - Edwards, Rodney K.

AU - Novak-Weekley, Susan M.

AU - Koty, Patrick P.

AU - Davis, Thomas

AU - Leeds, Leroy J.

AU - Jordan, Jeanne A.

PY - 2008/6

Y1 - 2008/6

N2 - OBJECTIVE:: To estimate the clinical performance characteristics of a real-time polymerase chain reaction (PCR) assay using vaginal/rectal swabs from antepartum (35-37 weeks of gestation) and intrapartum women. METHODS:: The assay evaluated is a qualitative, automated, real-time PCR test for the detection of group B streptococci, with results available in approximately 75 minutes. Enrollment in this multicenter clinical study occurred between October 2005 and January 2006. Vaginal/rectal swabs were analyzed by nursing personnel (intrapartum tests) or by laboratory technologists (all others). Polymerase chain reaction assay results were compared with culture using standard methods, including selective broth medium, and to a predicate nucleic acid amplification test. RESULTS:: Of 1,028 enrolled women, 234 were deemed ineligible, and 10 had unresolved test results. Of the 784 remaining women, valid PCR assay results were obtained on the first test attempt for 93.0%. Performance characteristics relative to culture were sensitivity 91.1%, specificity 96.0%, positive predictive value 87.8%, negative predictive value 97.1%, and accuracy 94.8%. These results exceeded those obtained using the predicate nucleic acid amplification test. CONCLUSION:: Performance characteristics of the PCR assay exceed the threshold recommended by the Centers for Disease Control and Prevention when compared with culture. The test is sufficiently robust to be performed for intrapartum patients in a point-of-care setting by medical professionals.

AB - OBJECTIVE:: To estimate the clinical performance characteristics of a real-time polymerase chain reaction (PCR) assay using vaginal/rectal swabs from antepartum (35-37 weeks of gestation) and intrapartum women. METHODS:: The assay evaluated is a qualitative, automated, real-time PCR test for the detection of group B streptococci, with results available in approximately 75 minutes. Enrollment in this multicenter clinical study occurred between October 2005 and January 2006. Vaginal/rectal swabs were analyzed by nursing personnel (intrapartum tests) or by laboratory technologists (all others). Polymerase chain reaction assay results were compared with culture using standard methods, including selective broth medium, and to a predicate nucleic acid amplification test. RESULTS:: Of 1,028 enrolled women, 234 were deemed ineligible, and 10 had unresolved test results. Of the 784 remaining women, valid PCR assay results were obtained on the first test attempt for 93.0%. Performance characteristics relative to culture were sensitivity 91.1%, specificity 96.0%, positive predictive value 87.8%, negative predictive value 97.1%, and accuracy 94.8%. These results exceeded those obtained using the predicate nucleic acid amplification test. CONCLUSION:: Performance characteristics of the PCR assay exceed the threshold recommended by the Centers for Disease Control and Prevention when compared with culture. The test is sufficiently robust to be performed for intrapartum patients in a point-of-care setting by medical professionals.

UR - http://www.scopus.com/inward/record.url?scp=47749090189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47749090189&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e31817710ee

DO - 10.1097/AOG.0b013e31817710ee

M3 - Article

C2 - 18515517

AN - SCOPUS:47749090189

VL - 111

SP - 1335

EP - 1341

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 6

ER -